Reimbursable drug classes and ceilings in Italy: why not only one?

Eur J Health Econ. 2016 Nov;17(8):923-926. doi: 10.1007/s10198-016-0808-z.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Intravenous
  • Decision Making, Organizational
  • Drug Costs
  • Economics, Pharmaceutical*
  • Health Policy
  • Hospitals
  • Humans
  • Insurance, Health, Reimbursement / economics*
  • Italy
  • National Health Programs / economics
  • Pharmaceutical Preparations / classification*
  • Pharmaceutical Preparations / economics*

Substances

  • Pharmaceutical Preparations